Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Treatment

Laetrile

Oncologic Therapy

Laetrile is a semisynthetic derivative of amygdalin, a cyanogenic compound found in apricot kernels and other plant seeds, patented in 1961 and marketed since the 1950s as a cancer treatment often mislabeled vitamin B17, though it is not a vitamin. A 500-milligram tablet can contain 2.5 to 25 milligrams of hydrogen cyanide, and a 2015 Cochrane Collaboration review concluded that claims of benefit for cancer patients are not supported by sound clinical data. The FDA banned interstate shipment in 1977, and although 27 states subsequently legalized amygdalin use within their own borders, the 1979 Supreme Court decision in United States v. Rutherford kept interstate transport illegal.

Facts
Classification
Status
Standard of Care 1
Origin Year
1830 2
Sources
1. Wikipedia
Wikipedia contributors, Wikimedia Foundationhttps://en.wikipedia.org/wiki/Amygdalin, lead section
Quote, https://en.wikipedia.org/wiki/Amygdalin, lead section
Amygdalin is a naturally occurring chemical compound found in many plants, such as the seeds of apricots, bitter almonds, apples, peaches, cherries and plums, and in the roots of manioc.
View the Source
2. Laetrile (Wikipedia)
Amygdalin first isolated in 1830 by Pierre-Jean Robiquet and Antoine Boutron-Charlard, History of laetrile sectionView the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.

View At A Past Year

Choose a year to see this entry's facts and connections as the atlas records them at that moment: what it held then, what it held instead, and what it had not yet adopted. Choose Present for the current record.